GDUFA III May Be Opportunity For Proactive Pharmacovigilance Discussions

 
• By Derrick Gingery
  
Blister Packs
FDA and sponsors may be interested in increasing communications related to generic drug pharmacovigilance activities. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Post-Marketing Regulation & Studies

More from Product Reviews